AMRZ reports half-year results on August 7 with one signal standing well above the rest: its own CEO bought the stock aggressively when it fell below CHF 50 in May, a cluster of insider purchases that now looks prescient given the shares have retreated further to CHF 41.81.
The insider buying tells a pointed story. Chairman and CEO Jan Jenisch made multiple open-market purchases on May 19, accumulating more than 15,000 shares across several transactions worth roughly CHF 610,000 at prices between CHF 48.50 and CHF 49.96. The CMO and CTO added smaller positions the following days. Across all insiders, net buying over the 90-day window reached nearly 83,000 shares with a combined value of around $4.2 million. That kind of coordinated executive buying — concentrated in a narrow three-day window — is rarely accidental, and it happened at prices roughly 15–20% above where the stock trades today.
The lending market offers no counterweight to that bullish signal. Borrow availability is exceptionally loose, running near 2,450% — meaning there are roughly 24 shares available to lend for every one already borrowed. Short pressure is minimal at best. The ORTEX short score is a subdued 29.9, well below levels that would suggest meaningful bearish conviction, and the cost to borrow is barely 0.66%, a trivially low hurdle for anyone wanting to establish a short position. Bears have the tools available but are not using them.
What the bulls can point to is a strong track record on earnings estimates: the company ranks in the 94th percentile on EPS surprise, meaning it has consistently delivered above expectations. EPS momentum is also constructive over both 30- and 90-day windows. The valuation has re-rated lower — the P/E multiple has compressed roughly 11% over the past month to around 16.7x, and price-to-book has eased to 1.8x — so the stock arrives at results cheaper than it was. Bears can argue the year-to-date decline of around 8% reflects genuine fundamental underperformance versus peers: HOLN has been broadly flat over the week while CRH is marginally positive and MLM has slipped only modestly. Amrize has lagged its building-materials peer group for most of 2026.
The prior two earnings reactions add an important note of caution. The April 30 print triggered an 11.3% single-day drop, followed by a further 8.1% decline over five days. A second event in late April also saw a negative reaction. The pattern of insider buying at higher prices, followed by consecutive weak prints, means today's release is less about short-term positioning and more about whether management can demonstrate the inflection that the CEO's own capital was betting on.
See the live data behind this article on ORTEX.
Open AMRZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
